Active ingredients
Mountain pine oil + peppermint oil + eucalyptus oil + a-tocopherol acetate + thymol
Release form
Drops
Composition
10 ml contains the active substance - ether-oil composition. Excipients: butyloxyanisole, labrafil M, rapeseed oil;
Pharmacological effect
Combined product, which includes a mixture of essential oils with natural substances in vegetable oil. The drug has anti-inflammatory, antimicrobial effect, enhances granulation. Pinosol improves the patient's condition, facilitating nasal breathing by reducing the secretion and increasing the patency of the nasal passages. In the chronic course of the disease, the drug enhances the blood circulation of the mucous membrane of the nose, larynx, trachea and helps to restore its function;
Pharmacokinetics
Data on the pharmacokinetics of the drug Pinosol is not provided;
Indications
Acute rhinitis; - chronic atrophic rhinitis; - acute and chronic inflammatory diseases of the mucous membranes of the nose and nasopharynx, accompanied by dry mucous membranes; - under conditions after surgery in the nasal cavity (in the hospital and on an outpatient basis);
Contraindications
Allergic rhinitis; - children's age up to 2 years; - hypersensitivity to the drug;
Use during pregnancy and lactation
Perhaps the use of Pinosol during pregnancy and lactation (breastfeeding) according to indications;
Dosage and administration
Adults on the 1st day of the drug instilled 1-2 drops in each nostril with an interval of 1-2 hours. In the following days - 1-2 drops in each nostril 3-4 times / day. Perhaps the use of the drug in the form of inhalation, which should be carried out with an inhaler. To do this, 2 ml (50 drops) are instilled into an inhaler; frequency of use - 2-3 times / day; Children are buried 1-2 drops 3-4 times / day or use a cotton swab .; The drug is used for 5-7 days;
Side effects
Local reactions: itching, burning sensation, redness and swelling of the nasal mucosa;
Overdose
When applied topically, the likelihood of an overdose of the drug Pinosol is unlikely;
special instructions
The patient should be informed that the development of adverse reactions should consult a doctor;
